His main research concerns Internal medicine, Hepatitis C, Gastroenterology, Immunology and Cirrhosis. He studies Internal medicine, focusing on Hepatology in particular. His studies in Hepatitis C integrate themes in fields like Ribavirin, Hepatitis C virus, Regimen, Pharmacotherapy and Alpha interferon.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Endocrinology, Liver transplantation and Liver biopsy. His Liver biopsy study which covers Fibrosis that intersects with Carcinoma. He interconnects Liver disease, Hepatocellular carcinoma, Surgery and Pathology in the investigation of issues within Cirrhosis.
Internal medicine, Gastroenterology, Immunology, Hepatitis C and Cirrhosis are his primary areas of study. His work is connected to Liver disease, Hepatocellular carcinoma, Hepatology, Liver biopsy and Hepatitis B, as a part of Internal medicine. His studies deal with areas such as Fibrosis, Biopsy and Cohort as well as Gastroenterology.
His work in Immunology addresses issues such as Virology, which are connected to fields such as Antigen. His Hepatitis C research includes elements of Pegylated interferon, Ribavirin, Hepatitis C virus, Pathology and Pharmacotherapy. His Cirrhosis study integrates concerns from other disciplines, such as Decompensation, Prospective cohort study, Surgery and Liver transplantation.
His main research concerns Internal medicine, Hepatitis B, Gastroenterology, Hepatitis B virus and Cirrhosis. His Internal medicine research incorporates themes from Coinfection and HBsAg, HBeAg. His research on Hepatitis B also deals with topics like
His biological study spans a wide range of topics, including Fibrosis and Biopsy, Liver biopsy. His research integrates issues of Clinical significance, Interquartile range, Hepatology and Hepatitis in his study of Hepatitis B virus. While the research belongs to areas of Cirrhosis, he spends his time largely on the problem of Hepatocellular carcinoma, intersecting his research to questions surrounding Hepatitis C virus, Interferon and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis, management, and treatment of hepatitis C: An update
Marc G. Ghany;Doris B. Strader;David L. Thomas;Leonard B. Seeff.
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany;David R. Nelson;Doris B. Strader;David L. Thomas.
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.
Kittichai Promrat;Glen Lutchman;Gabriel I. Uwaifo;Renee J. Freedman.
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok;Leonard B. Seeff;Timothy R. Morgan;Adrian M. di Bisceglie.
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz.
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
Mitchell L. Shiffman;Adrian M. Di Bisceglie;Karen L. Lindsay;Chihiro Morishima.
Outcome of sustained virological responders with histologically advanced chronic hepatitis C
Timothy R. Morgan;Timothy R. Morgan;Marc G. Ghany;Hae Young Kim;Kristin K. Snow.
Current and future therapies for hepatitis C virus infection.
T. Jake Liang;Marc G. Ghany.
The New England Journal of Medicine (2013)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie;Mitchell L. Shiffman;Gregory T. Everson;Karen L. Lindsay.
The New England Journal of Medicine (2008)
Long‐term therapy of chronic hepatitis B with lamivudine
Daryl T.‐Y. Lau;M. Farooq Khokhar;Edward Doo;Marc G. Ghany.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: